27 Feb 2026Open access
Identification of Antibiofilm Agents against <i>Salmonella enterica</i> from the Pathogen Box Compound LibraryPublisher sitebioRxiv (Cold Spring Harbor Laboratory), Bacterial biofilms and quorum sensing
UniversitiesOlayinka Kotila
Active, last published 2026
In malaria research and control
Olayinka
Kotila
Scholar“Research focused on Malaria Research and Control and adjacent fields.”
University of Ibadan
Claim Your Profile7
H-index
197
Citations
Olayinka has not officially claimed their profile. If you are Olayinka, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
layinka Kotila is a researcher working on Malaria Research and Control. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Olayinka's work has been cited 197 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Malaria Research and Control×5Ethics in Clinical Research×4Drug-Induced Adverse Reactions×4Global Health and Surgery×4Breast Cancer Treatment Studies×3
04 · Where I am
Affiliations
Affiliation on published researchUniversity of IbadanDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
6 works6 Apr 2025Open access1cites
Novel dietary herbal preparations with inhibitory activities against multiple SARS-CoV-2 targets: A multidisciplinary investigation into antiviral activitiesPublisher siteFood Chemistry Advances, Pharmacological Effects of Natural Compounds
12 Jan 2024Open access
Building capacity for drug development process in Africa‒A workable modelPublisher sitePharmacy Education, Pharmaceutical Economics and Policy
1 Jan 2024Open access
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Taxotere and Trastuzumab in Nigerian Women with Her2-Positive Breast Cancer (ARETTA): First Report from the Nigerian Breast Cancer Study GroupPublisher siteSSRN Electronic Journal, Breast Cancer Treatment Studies
25 Jul 2023Open access3cites
Non‐compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot studyPublisher siteBritish Journal of Clinical Pharmacology, Drug-Induced Adverse Reactions
1 Mar 2023
Abstract OT2-21-01: Assessing Response to neoadjuvant Taxotere and TrAstuzumab in Nigerian women with HER2-positive breast cancer (ARETTA)Publisher siteCancer Research, Breast Cancer Treatment Studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Olayinka?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you